Recent developments in HIV protease inhibitor therapy

被引：80

|

作者：

Molla, A ^{[1
]}

Granneman, GR ^{[1
]}

Sun, E ^{[1
]}

Kempf, DJ ^{[1
]}

机构：

[1] Abbott Labs, Div Pharmaceut Prod, Abbott Pk, IL 60064 USA

来源：

ANTIVIRAL RESEARCH | 1998年 / 39卷 / 01期

关键词：

protease inhibitors; HIV therapy; resistance; antiviral; genotypic patterns in resistance;

D O I：

10.1016/S0166-3542(98)00011-4

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

收藏

页码：1 / 23

页数：23

相关论文

共 50 条

[1] Recent developments in HIV protease inhibitor research
Chrusciel, RA
Romines, KR
EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (02) : 111 - 121
[2] Protease inhibitor therapy in HIV infection
Del Sorbo, F
Meraviglia, P
Angeli, E
Mainini, A
Dedivitiis, GF
Cargnel, A
AIDS AND RELATED SYNDROMES, 2001, : 349 - 354
[3] Lipodystrophy is a concern with HIV protease inhibitor therapy
不详
Drugs & Therapy Perspectives, 1998, 12 (9) : 11 - 13
[4] Recent Developments of Peptidomimetic HIV-1 Protease Inhibitors
Qiu, X.
Liu, Z. -P.
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (29) : 4513 - 4537
[5] Tipranavir: A protease inhibitor for HIV salvage therapy
Dong, Betty J.
Cocohoba, Jennifer M.
ANNALS OF PHARMACOTHERAPY, 2006, 40 (7-8) : 1311 - 1321
[6] Effects of HIV protease inhibitor therapy on lipid metabolism
Hui, DY
PROGRESS IN LIPID RESEARCH, 2003, 42 (02) : 81 - 92
[7] Protease inhibitor plasma concentrations in HIV antiretroviral therapy
Justesen, Ulrik Stenz
DANISH MEDICAL BULLETIN, 2008, 55 (04) : 165 - 185
[8] Metabolic Complications Associated with HIV Protease Inhibitor Therapy
David Nolan
Drugs, 2003, 63 : 2555 - 2574
[9] The role of protease inhibitor therapy in children with HIV infection
Gavin P.J.
Yogev R.
Pediatric Drugs, 2002, 4 (9) : 581 - 607
[10] Protease inhibitor therapy in HIV-infected children
Feingold, AR
Rutstein, RM
Meislich, D
Brown, T
Rudy, BJ
AIDS PATIENT CARE AND STDS, 2000, 14 (11) : 589 - 593

← 1 2 3 4 5 →